Equities
  • Price (CHF)3,904.00
  • Today's Change3.00 / 0.08%
  • Shares traded16.60k
  • 1 Year change+27.46%
  • Beta0.9692
Data delayed at least 15 minutes, as of Nov 08 2024 16:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Givaudan SA is a Switzerland-based company engaged in the fragrance and flavor industry. The Company has two business divisions: Fragrances and Flavors. The Fragrances segment comprises the manufacture and sale of fragrances through four business units: Fine Fragrances, comprising fragrances; Consumer Products, comprising personal care, hair and skin care, household care, and oral care; Fragrance Ingredients; and Cosmetics Activities, comprising cosmetics. The Flavors business division comprises the manufacture and sale of flavors into four business units: Beverages, comprising flavors for soft drinks, fruit juices and instant beverages; Dairy, comprising ice cream, yoghurt, desserts and yellow fats; Savory, covering soups and sauces; and Confectionery. The Company also engages in research and development activities into perfumery raw materials, both synthetic and natural. It operates through Induchem Holding AG and Activ International, among others.

  • Revenue in CHF (TTM)7.12bn
  • Net income in CHF1.03bn
  • Incorporated1929
  • Employees16.36k
  • Location
    Givaudan SAChemin de la Parfumerie 5VERNIER 1214SwitzerlandCHE
  • Phone+41 227809111
  • Fax+41 227809150
  • Websitehttps://www.givaudan.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GIVN:SWX since
announced
Transaction
value
B Kolormakeup & Skincare SpA SbDeal completed01 Jul 202401 Jul 2024Deal completed-8.36%--
Data delayed at least 15 minutes, as of Nov 08 2024 16:31 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Syensqo NV-93.85bn-93.85bn7.69bn13.05k--1.10----------70.43------------------------1.08--0.2239---13.02---79.68------
Evonik Industries AG14.23bn213.98m8.01bn33.58k38.130.94646.590.56290.48030.480332.0219.350.75144.228.64453,859.801.212.011.542.4225.2525.471.612.900.73719.950.3168130.72-17.422.85-186.27---3.510.3454
Imcd NV4.26bn263.57m8.18bn5.01k31.004.9821.351.924.934.9379.7430.721.085.535.22958,630.506.667.019.669.6022.3721.406.195.800.88465.670.508744.25-3.4513.30-6.6523.9124.0922.87
Brenntag SE15.21bn565.55m8.27bn17.96k15.092.018.750.54334.044.04108.4430.291.487.936.40915,370.705.576.407.889.0224.4823.033.764.021.2113.140.44337.40-13.456.03-19.389.1812.4711.84
Akzo Nobel NV9.97bn530.26m9.43bn35.40k17.792.2010.280.94583.313.2961.9626.800.69913.573.75301,733.004.004.156.596.0640.8240.515.726.070.89474.710.565163.75-1.642.8823.482.2512.321.41
Symrise AG4.58bn368.26m14.12bn12.54k38.374.0021.333.082.812.8134.9226.900.61862.404.94392,584.405.024.995.805.9537.1037.938.118.131.647.170.40143.832.428.4421.594.043.444.10
Ems Chemie Holding AG2.09bn461.97m15.20bn2.77k32.917.6129.397.2719.7519.7589.4685.440.8586--6.07764,838.1019.1322.7222.1127.29--45.0222.2823.253.72245.250.015387.87-10.36-1.14-14.01-2.51-3.871.57
Novozymes A/S2.86bn265.70m22.10bn10.45k61.182.4037.207.736.926.9267.31176.570.322.665.053,551,443.002.9613.463.4317.8446.6755.569.2520.120.68712.090.153138.891.824.47-17.86-1.288.124.41
Givaudan SA7.12bn1.03bn36.05bn16.36k35.038.3526.055.07111.45111.45768.58467.470.59942.724.13437,619.108.697.4111.549.0142.7741.0714.5012.080.939429.580.552375.20-2.844.584.326.149.272.53
BASF SE61.26bn467.38m36.34bn112.08k77.761.116.690.59320.5580.55873.1338.920.8063.315.76582,850.400.80511.681.042.1925.5424.960.99892.001.03--0.3823247.02-21.102.73135.89-43.316.741.22
Sika AG11.70bn1.25bn38.53bn33.55k31.41--21.563.297.647.6472.67--------348,892.60--9.25--11.5054.8052.4910.6710.34--9.58--39.687.129.67-8.659.233.249.99
L'Air Liquide Sct nnym pr l'td t l'xpltt25.35bn2.85bn87.64bn66.30k30.713.7716.523.465.265.2646.7742.860.54865.068.93398,446.406.456.018.277.3861.5459.6911.7511.070.570718.760.341856.32-7.775.6111.577.818.577.88
Data as of Nov 08 2024. Currency figures normalised to Givaudan SA's reporting currency: Swiss Franc CHF

Institutional shareholders

29.47%Per cent of shares held by top holders
HolderShares% Held
Bill & Melinda Gates Foundation Trust (Investment Management)as of 31 Dec 20231.28m13.86%
UBS Asset Management Switzerland AGas of 30 Jun 2023287.86k3.12%
The Vanguard Group, Inc.as of 02 Oct 2024287.20k3.11%
Norges Bank Investment Managementas of 30 Jun 2024184.58k2.00%
BlackRock Fund Advisorsas of 03 Oct 2024172.33k1.87%
Pictet Asset Management SAas of 30 Sep 2024124.15k1.35%
Geode Capital Management LLCas of 31 Oct 2024119.79k1.30%
Z�rcher Kantonalbank (Investment Management)as of 30 Aug 2024112.55k1.22%
BlackRock Advisors (UK) Ltd.as of 03 Oct 2024104.84k1.14%
Union Investment Privatfonds GmbHas of 31 Mar 202447.96k0.52%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.